SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-QT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0000950123-05-001404
Filing Date
2005-02-09
Accepted
2005-02-09 16:43:31
Documents
8
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC y05537e10vqt.txt 10-QT 130038
2 SERVICE CONTRACT y05537exv10w1.txt EX-10.1 20086
3 ADDENDUM TO EMPLOYMENT AGREEMENT y05537exv10w2.txt EX-10.2 2418
4 LETTER OF EMPLOYMENT y05537exv10w3.txt EX-10.3 13791
5 CERTIFICATION y05537exv31w1.txt EX-31.1 3557
6 CERTIFICATION y05537exv31w2.txt EX-31.2 3420
7 CERTIFICATION y05537exv32w1.txt EX-32.1 1367
8 CERTIFICATION y05537exv32w2.txt EX-32.2 1390
  Complete submission text file 0000950123-05-001404.txt   178600
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: 10-QT | Act: 34 | File No.: 000-15190 | Film No.: 05589231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances